Diane M. Pascoe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Diane M. Pascoe has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Mark W. McCusker
Department of Radiology Royal Melbourne Hospital Melbourne Victoria Australia
3 shared publications Catherine M. Jones
I‐MED Radiology Brisbane Queensland Australia
2 shared publications- Miranda Siemienowicz
Northern Imaging Victoria Northern Health Epping Victoria Australia
2 shared publications - Samantha Ellis
Department of Radiology Alfred Health Melbourne Victoria Australia
2 shared publications Stephen Melsom
Department of Medical Imaging Fiona Stanley Hospital Murdoch Western Australia Australia
2 shared publicationsAndrew Coote
Electronic Medical Record Team, Royal Melbourne Hospital, Parkville VIC 3050
1 shared publication
Latest Publications
- Open Access
- 27 February 2026
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 70 (3) , 294-303
Rationale for the Nodule Management Protocol of the Australian National Lung Cancer Screening Program
In July 2022, the Australian Medical Services Advisory Committee (MSAC) recommended the establishment of an Australian NLCSP (National Lung Cancer Screening Program), using low‐dose computed tomography (LDCT) for the early detection of lung cancer in asymptomatic high‐risk individuals. MSAC's recommendations for the NLCSP included core requirements as follows: (i) routine biennial screening, (ii) use of the PanCan risk prediction model for reporting baseline LDCT, and (iii) the use of the most recent version of Lung‐RADS for reporting follow‐up LDCT. Necessary adaptations were made to incorporate these requirements, resulting in a bespoke protocol for the Australian context. This article summarises the rationale and development of the NLCSP Nodule Management Protocol.
- 27 February 2026
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 70 (3) , 294-303
Open AccessRationale for the Nodule Management Protocol of the Australian National Lung Cancer Screening Program
In July 2022, the Australian Medical Services Advisory Committee (MSAC) recommended the establishment of an Australian NLCSP (National Lung Cancer Screening Program), using low‐dose computed tomography (LDCT) for the early detection of lung cancer in asymptomatic high‐risk individuals. MSAC's recommendations for the NLCSP included core requirements as follows: (i) routine biennial screening, (ii) use of the PanCan risk prediction model for reporting baseline LDCT, and (iii) the use of the most recent version of Lung‐RADS for reporting follow‐up LDCT. Necessary adaptations were made to incorporate these requirements, resulting in a bespoke protocol for the Australian context. This article summarises the rationale and development of the NLCSP Nodule Management Protocol.
- Open Access
- 16 August 2025
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 69 (7) , 740-744
The Australian National Lung Cancer Screening Program: A Radiologist's Perspective
On July 1, 2025, Australia commenced screening eligible participants in a ground‐breaking health initiative with the launch of a national lung cancer screening program (NLCSP). Designed for individuals at high risk, this program aims to promote early detection and improve both survival rates and treatment outcomes. Radiology will serve as a cornerstone of the program's success. This article provides a comprehensive overview from the radiologist's perspective.
- 16 August 2025
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 69 (7) , 740-744
Open AccessThe Australian National Lung Cancer Screening Program: A Radiologist's Perspective
On July 1, 2025, Australia commenced screening eligible participants in a ground‐breaking health initiative with the launch of a national lung cancer screening program (NLCSP). Designed for individuals at high risk, this program aims to promote early detection and improve both survival rates and treatment outcomes. Radiology will serve as a cornerstone of the program's success. This article provides a comprehensive overview from the radiologist's perspective.